Response of Vestibular Schwannomas in NF2-Related Schwannomatosis (NF2-SWN) to Losartan: A Case Series

Evidence is too preliminary (small single-institution case series, no control group) to justify adding losartan to NF2-SWN management outside of a research protocol; no actionable practice change at this time.